US 7919473
IRNA agents targeting VEGF
granted A61KA61K31/7088A61K31/712
Quick answer
US patent 7919473 (IRNA agents targeting VEGF) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/7088, A61K31/712, A61K31/713, A61K47/02